首页> 外国专利> Radiotracers for in vivo study of acetylcholinesterase and Alzheimer's disease

Radiotracers for in vivo study of acetylcholinesterase and Alzheimer's disease

机译：放射性示踪剂，用于体内研究乙酰胆碱酯酶和阿尔茨海默氏病

页面导航

摘要
著录项
相似文献

摘要

Radio-labeled compounds of the formula are useful as in vivo imaging agents for diagnosis of Alzheimer's disease.

机译：放射性标记的式<图像文件=“ 80000001.GIF” he =“ 53” imgContent =“ chem” imgFormat =“ GIF” inline =“ no” direction =“ portrait” wi =“ 80” />的化合物很有用作为体内成像剂用于诊断阿尔茨海默氏病。 展开▼

著录项

公开/公告号EP1048302A3

专利类型

公开/公告日2002-07-17

原文格式PDF

申请/专利权人 PFIZER PRODUCTS INC.;
展开▼

申请/专利号EP20000303348

发明设计人 BENCHERIF BADREDDINE JOHN HOPKINS UNIVERSITY;FROST JAMES J.;DANNALS ROBERT F.;MUSACHIO JOHN;SCHEFFEL URSULA;VILLALOBOS ANABELLA DEPARTEMENT OF NEUROSCIENCE;
展开▼

申请日2000-04-20

分类号A61K51/04;A61K31/424;A61K31/429;A61K31/4188;

国家 EP

入库时间 2022-08-22 00:34:55

相似文献

专利

外文文献

中文文献

1. 用于治疗阿尔茨海默氏病的双结合位点乙酰胆碱酯酶抑制剂 [P] . 中国专利： CN100436421C . 2008.11.26

2. 用于治疗阿尔茨海默氏病的双结合位点乙酰胆碱酯酶抑制剂 [P] . 中国专利： CN1703220A . 2005-11-30

3. Radiotracers for in vivo study of acetylcholinesterase and Alzheimer's disease [P] . 美国专利： US2005100509A1 . 2005-05-12

机译：放射性示踪剂，用于体内研究乙酰胆碱酯酶和阿尔茨海默氏病

4. Radiotracers for in vivo study of acetylcholinesterase and Alzheimer's disease [P] . AU767726B2 . 2003-11-20

机译：放射性示踪剂，用于体内研究乙酰胆碱酯酶和阿尔茨海默氏病

5. Radiotracers for in vivo study of acetylcholinesterase and alzheimer's disease [P] . 美国专利： US2002064500A1 . 2002-05-30

机译：用于体内研究乙酰胆碱酯酶和阿尔茨海默氏病的放射性示踪剂

1. Correlation between iron deposition and Alzheimer＇s disease--In vivo preliminary quantitative study with susceptibility-weighted imaging [J] . Jun Zhang, Jianhong Wang, Ke Li, 中国神经再生研究：英文版 . 2010,第010期

2. Correlation between iron deposition and Alzheimer's disease In vivo preliminary quantitative study with susceptibility-weighted imaging [J] . Jun Zhang, Chenggong Yan, Jianhong Wang, 中国神经再生研究（英文版） . 2010,第010期

3. Novel ligand-based docking; molecular dynamic simulations; and absorption, distribution, metabolism, and excretion approach to analyzing potential acetylcholinesterase inhibitors for Alzheimer's disease [J] . Subramaniyan Vijayakumar, Palani Manogar, Srinivasan Prabhu, 药物分析学报（英文） . 2018,第006期

4. Acetylcholinesterase inhibitor modiifcations：a promising strategy to delay the progression of Alzheimer’s disease [J] . Soumee Bhattacharya, Dirk Montag 中国神经再生研究（英文版） . 2015,第001期

5. Mutations in GBA, SNCA, and VPS35 are not associated with Alzheimer 's disease in a Chinese population: a case-control study [J] . Ya-Fei Wen, Jun-Ling Wang, Xin-Xin Liao, 中国神经再生研究（英文版） . 2022,第003期

6. Preparation and in vitro and in vivo studies of Huperzine A loaded microspheres for the treatment of Alzheimer′s disease [C] . Controlled Release Society annual meeting . 2004

7. Effects of G-CSF on Monocytes and Neurons: In vitro and in vivo studies in a Mouse Model of Alzheimer's Disease. [D] . Pennington, Amanda Renee. 2012

8. In vivo Evaluation of a Newly Synthesized Acetylcholinesterase Inhibitor in a Transgenic Drosophila Model of Alzheimer’s Disease [O] . Giuseppe Uras, Alessia Manca, Pengfei Zhang, 2021

9. In vivo Evaluation of a Newly Synthesized Acetylcholinesterase Inhibitor in a Transgenic Drosophila Model of Alzheimer’s Disease [O] . Giuseppe Uras, Alessia Manca, Pengfei Zhang, 2021

10. Radiotracers in PETT: Strategies for in Vivo Receptor Activity, Schizophernia, and Alzheimer's Dementia Studies [R] . Wolf, A. P. 1984

1. 脑乙酰胆碱酯酶PET显像剂-11CMP4A在大鼠体内分布的研究 [C] . 周玲 ,管一晖 ,薛方平 . 全国稳定同位素新技术开发与应用交流研讨 . 2011

2. 淡色库蚊和鲫鱼体内乙酰胆碱酯酶的生物化学性质比较研究 [A] . 仪美芹 . 2006